Trial Profile
1/2-Multi-site Study: Varenicline Treatment of Alcohol Dependent Smokers
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Varenicline (Primary)
- Indications Alcoholism
- Focus Therapeutic Use
- 03 Jan 2018 New trial record
- 20 Dec 2017 Primary endpoint (Percentage of heavy drinking days during the last 8 weeks of treatment) has not been met as per the results published in the JAMA Psychiatry
- 20 Dec 2017 Results (data cut off August 31, 2015) assessing safety and efficacy published in the JAMA Psychiatry